Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New approaches for antirheumatic therapy.

B Kirkham, G S Panayi

    Bailliere'S Clinical Rheumatology
    |December 1, 1990
    PubMed
    Summary
    This summary is machine-generated.

    New antirheumatic therapies target specific immune pathways, avoiding broad immunosuppression. Research focuses on T cell receptors, HLA antigens, and antigenic peptides for precise treatment of autoimmune diseases like rheumatoid arthritis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single-centre, prospective 1-year observational cohort study of the first 100 patients treated.

    The British journal of dermatology·2020
    Same author

    Development of inflammatory arthritis and enthesitis in patients on dupilumab: a case series.

    The British journal of dermatology·2019
    Same author

    The frequency of remission and low disease activity in patients with rheumatoid arthritis, and their ability to identify people with low disability and normal quality of life.

    Seminars in arthritis and rheumatism·2019
    Same author

    Tumour necrosis factor antagonist-induced lupus: a Critically Appraised Topic.

    The British journal of dermatology·2017
    Same author

    Prostaglandin regulation of B-lymphocyte function.

    Immunology today·2014
    Same author

    Self-Ia reactive T cells in autoimmunity.

    Immunology today·2014

    Area of Science:

    • Immunology
    • Rheumatology
    • Therapeutic Development

    Background:

    • Current antirheumatic therapies often involve generalized immunosuppression with potential side effects.
    • Understanding immunopathogenic processes is key to developing targeted treatments.

    Purpose of the Study:

    • To explore novel, specific immunotherapies for rheumatic diseases.
    • To move beyond generalized immunosuppression towards targeted interventions.

    Main Methods:

    • Utilizing monoclonal antibodies against T cell antigens (e.g., CD4, CD7, IL-2 receptor) and HLA molecules.
    • Investigating therapeutic vaccines using disease-causing T cell lines.
    • Developing peptide-based therapies to displace disease-inducing antigenic peptides.

    Related Experiment Videos

    Main Results:

    • Specific immunotherapy targets include T cell receptors, disease-linked HLA antigens, and critical antigenic peptides.
    • Monoclonal antibodies and T cell line therapies show promise.
    • Engineered peptides offer a precise immunotherapy approach by displacing problematic antigens.

    Conclusions:

    • New therapies aim for transient immune system modulation to allow natural regulatory circuits to restore balance.
    • Combination therapies may be necessary for achieving a cure.
    • Collaboration between researchers and clinicians is essential for advancing these treatments.